138 related articles for article (PubMed ID: 24033267)
21. An evaluation of cytotoxicity of the taxane and platinum agents combination treatment in a panel of human ovarian carcinoma cell lines.
Smith JA; Ngo H; Martin MC; Wolf JK
Gynecol Oncol; 2005 Jul; 98(1):141-5. PubMed ID: 15963813
[TBL] [Abstract][Full Text] [Related]
22. The enriched fraction of Vernonia cinerea L. induces apoptosis and inhibits multi-drug resistance transporters in human epithelial cancer cells.
Appadath Beeran A; Maliyakkal N; Rao CM; Udupa N
J Ethnopharmacol; 2014 Dec; 158 Pt A():33-42. PubMed ID: 25456421
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of pancreatic cancer and potentiation of gemcitabine effects by the extract of Pao Pereira.
Yu J; Drisko J; Chen Q
Oncol Rep; 2013 Jul; 30(1):149-56. PubMed ID: 23674070
[TBL] [Abstract][Full Text] [Related]
24. Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Carboplatin Effects Against Ovarian Cancer.
Yu J; Ma Y; Drisko J; Chen Q
Curr Ther Res Clin Exp; 2013 Dec; 75():8-14. PubMed ID: 24465036
[TBL] [Abstract][Full Text] [Related]
25. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.
Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; De Placido S; Bianco AR; Tortora G
Clin Cancer Res; 2000 May; 6(5):2053-63. PubMed ID: 10815932
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo antitumor activity of a methanol extract of Dregea volubilis leaves with its antioxidant effect.
Hossain E; Chakroborty S; Milan A; Chattopadhyay P; Mandal SC; Gupta JK
Pharm Biol; 2012 Mar; 50(3):338-43. PubMed ID: 22239161
[TBL] [Abstract][Full Text] [Related]
27. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
Tong L; Chen W; Wu J; Li H
Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of combined bevacizumab and intraperitoneal carboplatin or paclitaxel therapy in a mouse model of ovarian cancer.
Shah DK; Veith J; Bernacki RJ; Balthasar JP
Cancer Chemother Pharmacol; 2011 Oct; 68(4):951-8. PubMed ID: 21305289
[TBL] [Abstract][Full Text] [Related]
29. The fractionated Toona sinensis leaf extract induces apoptosis of human ovarian cancer cells and inhibits tumor growth in a murine xenograft model.
Chang HL; Hsu HK; Su JH; Wang PH; Chung YF; Chia YC; Tsai LY; Wu YC; Yuan SS
Gynecol Oncol; 2006 Aug; 102(2):309-14. PubMed ID: 16466781
[TBL] [Abstract][Full Text] [Related]
30. Sensitization by interleukin-1alpha of carboplatinum anti-tumor activity against human ovarian (NIH:OVCAR-3) carcinoma cells in vitro and in vivo.
Wang Z; Lee KB; Reed E; Sinha BK
Int J Cancer; 1996 Nov; 68(5):583-7. PubMed ID: 8938138
[TBL] [Abstract][Full Text] [Related]
31. Antitumor effects of Origanum acutidens extracts on human breast cancer.
Tuncer E; Unver-Saraydin S; Tepe B; Karadayi S; Ozer H; Karadayi K; Inan D; Elagoz S; Polat Z; Duman M; Turan M
J BUON; 2013; 18(1):77-85. PubMed ID: 23613392
[TBL] [Abstract][Full Text] [Related]
32. Anticancer activity of Berberis aristata in Ehrlich ascites carcinoma-bearing mice: a preliminary study.
Pai KS; Srilatha P; Suryakant K; Setty MM; Nayak PG; Rao CM; Baliga MS
Pharm Biol; 2012 Mar; 50(3):270-7. PubMed ID: 22085276
[TBL] [Abstract][Full Text] [Related]
33. Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs.
Tomek S; Horak P; Pribill I; Haller G; Rössler M; Zielinski CC; Pils D; Krainer M
Gynecol Oncol; 2004 Jul; 94(1):107-14. PubMed ID: 15262127
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of cytotoxic activity of patriscabratine, tetracosane and various flavonoids isolated from the Bangladeshi medicinal plant Acrostichum aureum.
Uddin SJ; Grice D; Tiralongo E
Pharm Biol; 2012 Oct; 50(10):1276-80. PubMed ID: 22906240
[TBL] [Abstract][Full Text] [Related]
35. Prevention of carboplatin-induced resistance in human ovarian tumor xenografts by selenite.
Caffrey PB; Frenkel GD
Anticancer Res; 2013 Oct; 33(10):4249-54. PubMed ID: 24122988
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis-based evaluation of chemosensitivity in ovarian cancer patients.
Flick MB; O'Malley D; Rutherford T; Rodov S; Kamsteeg M; Hao XY; Schwartz P; Kacinski BM; Mor G
J Soc Gynecol Investig; 2004 May; 11(4):252-9. PubMed ID: 15120700
[TBL] [Abstract][Full Text] [Related]
37. The combination of the tyrosine kinase receptor inhibitor SU6668 with paclitaxel affects ascites formation and tumor spread in ovarian carcinoma xenografts growing orthotopically.
Garofalo A; Naumova E; Manenti L; Ghilardi C; Ghisleni G; Caniatti M; Colombo T; Cherrington JM; Scanziani E; Nicoletti MI; Giavazzi R
Clin Cancer Res; 2003 Aug; 9(9):3476-85. PubMed ID: 12960140
[TBL] [Abstract][Full Text] [Related]
38. Anticancer activities of Oldenlandia diffusa.
Gupta S; Zhang D; Yi J; Shao J
J Herb Pharmacother; 2004; 4(1):21-33. PubMed ID: 15273074
[TBL] [Abstract][Full Text] [Related]
39. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.
Shalinsky DR; Brekken J; Zou H; Bloom LA; McDermott CD; Zook S; Varki NM; Appelt K
Clin Cancer Res; 1999 Jul; 5(7):1905-17. PubMed ID: 10430098
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancer.
Arend RC; Londoño-Joshi AI; Samant RS; Li Y; Conner M; Hidalgo B; Alvarez RD; Landen CN; Straughn JM; Buchsbaum DJ
Gynecol Oncol; 2014 Jul; 134(1):112-20. PubMed ID: 24736023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
